Detalles de la búsqueda
1.
Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
Bioorg Med Chem
; 24(4): 596-605, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26740153
2.
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings.
Bioorg Med Chem
; 22(1): 167-77, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24332657
3.
High-level expression, purification, and characterization of Staphylococcus aureus dihydroorotase (PyrC) as a cleavable His-SUMO fusion.
Protein Expr Purif
; 88(1): 98-106, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23246866
4.
Fragment-based drug discovery using a multidomain, parallel MD-MM/PBSA screening protocol.
J Chem Inf Model
; 53(3): 560-72, 2013 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-23432621
5.
Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening.
J Chem Inf Model
; 52(8): 2245-56, 2012 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22697413
6.
Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
ACS Chem Biol
; 10(6): 1456-65, 2015 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25746232
7.
Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications.
ChemMedChem
; 8(8): 1361-72, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23788528
8.
High-throughput screening (HTS) and hit validation to identify small molecule inhibitors with activity against NS3/4A proteases from multiple hepatitis C virus genotypes.
PLoS One
; 8(10): e75144, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24130685
Resultados
1 -
8
de 8
1
Próxima >
>>